1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Biopharmaceuticals Market, By Product Type
5.1 Introduction
5.2 Monoclonal Antibodies
5.2.1 Anti-cancer Monoclonal Antibodies
5.2.2 Anti-inflammatory Monoclonal Antibodies
5.3 Interferon
5.4 Insulin
5.5 Growth and Coagulation Factor
5.6 Vaccines
5.6.1 Recombinant Vaccines
5.6.1.1 Cancer Vaccine
5.6.1.2 Malaria Vaccine
5.6.1.3 Ebola Vaccine
5.6.1.4 Hepatitis-B Vaccine
5.6.1.5 Tetanus Vaccine
5.6.1.6 Diphtheria Vaccine
5.6.1.7 Cholera Vaccine
5.6.2 Conventional Vaccines
5.6.2.1 Polio Vaccine
5.6.2.2 Pox Vaccine
5.7 Recombinant Growth Factors
5.7.1 Erythropoietin
5.7.2 Granulocyte Colony Stimulating Factor
5.8 Purified Proteins
5.8.1 Leukemia Inhibitory Factor (LIF)
5.8.2 P53 Protein
5.8.3 P38 Protein
5.9 Recombinant Proteins
5.9.1 Serum Albumin
5.9.2 Amyloid Protein
5.9.3 Defensin
5.9.4 Transferrin
5.10 Synthetic Immunomodulators
5.11 Recombinant Hormones
5.11.1 Recombinant Human Growth Hormones
5.11.2 Recombinant Insulin
5.12 Recombinant Enzymes
5.12.1 Enterokinase
5.12.2 Cyclase
5.12.3 Caspase
5.12.4 Cathepsin
5.13 Cell and Gene Therapies
5.13.1 Allogenic Products
5.13.2 Autologous Products
5.13.3 Acellular Products
5.14 Synthetic Immunomodulators
5.14.1 Cytokines
5.14.2 Interferons
5.14.3 Interleukins
5.15 Other Product Types
6 Global Biopharmaceuticals Market, By Application
6.1 Introduction
6.2 Oncology
6.3 Blood disorder
6.4 Metabolic disease
6.5 Infectious disease
6.6 Cardiovascular disease
6.7 Neurological disease
6.8 Immunology
6.9 Autoimmune Disorders
6.10 Hormonal Disorders
6.11 Other Applications
7 Global Biopharmaceuticals Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Merck & Co., Inc.
9.2 Novartis AG
9.3 Abbott Laboratories.
9.4 Novo Nordisk A/S
9.5 Eli Lilly and Company
9.6 AstraZeneca PLC
9.7 Bristol-Myers Squibb Company
9.8 Biogen Inc.
9.9 AbbVie Inc.
9.10 Pfizer Inc.
9.11 Bausch Health Companies Inc.
9.12 F. Hoffmann-La Roche AG
9.13 Sanofi
9.14 Bayer AG
9.15 Allergan plc
9.16 Johnson & Johnson
9.17 Amgen Inc.
List of Tables
Table 1 Global Biopharmaceuticals Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Biopharmaceuticals Market Outlook, By Product Type (2021-2030) ($MN)
Table 3 Global Biopharmaceuticals Market Outlook, By Monoclonal Antibodies (2021-2030) ($MN)
Table 4 Global Biopharmaceuticals Market Outlook, By Anti-cancer Monoclonal Antibodies (2021-2030) ($MN)
Table 5 Global Biopharmaceuticals Market Outlook, By Anti-inflammatory Monoclonal Antibodies (2021-2030) ($MN)
Table 6 Global Biopharmaceuticals Market Outlook, By Interferon (2021-2030) ($MN)
Table 7 Global Biopharmaceuticals Market Outlook, By Insulin (2021-2030) ($MN)
Table 8 Global Biopharmaceuticals Market Outlook, By Growth and Coagulation Factor (2021-2030) ($MN)
Table 9 Global Biopharmaceuticals Market Outlook, By Vaccines (2021-2030) ($MN)
Table 10 Global Biopharmaceuticals Market Outlook, By Recombinant Vaccines (2021-2030) ($MN)
Table 11 Global Biopharmaceuticals Market Outlook, By Conventional Vaccines (2021-2030) ($MN)
Table 12 Global Biopharmaceuticals Market Outlook, By Recombinant Growth Factors (2021-2030) ($MN)
Table 13 Global Biopharmaceuticals Market Outlook, By Erythropoietin (2021-2030) ($MN)
Table 14 Global Biopharmaceuticals Market Outlook, By Granulocyte Colony Stimulating Factor (2021-2030) ($MN)
Table 15 Global Biopharmaceuticals Market Outlook, By Purified Proteins (2021-2030) ($MN)
Table 16 Global Biopharmaceuticals Market Outlook, By Leukemia Inhibitory Factor (LIF) (2021-2030) ($MN)
Table 17 Global Biopharmaceuticals Market Outlook, By P53 Protein (2021-2030) ($MN)
Table 18 Global Biopharmaceuticals Market Outlook, By P38 Protein (2021-2030) ($MN)
Table 19 Global Biopharmaceuticals Market Outlook, By Recombinant Proteins (2021-2030) ($MN)
Table 20 Global Biopharmaceuticals Market Outlook, By Serum Albumin (2021-2030) ($MN)
Table 21 Global Biopharmaceuticals Market Outlook, By Amyloid Protein (2021-2030) ($MN)
Table 22 Global Biopharmaceuticals Market Outlook, By Defensin (2021-2030) ($MN)
Table 23 Global Biopharmaceuticals Market Outlook, By Transferrin (2021-2030) ($MN)
Table 24 Global Biopharmaceuticals Market Outlook, By Synthetic Immunomodulators (2021-2030) ($MN)
Table 25 Global Biopharmaceuticals Market Outlook, By Recombinant Hormones (2021-2030) ($MN)
Table 26 Global Biopharmaceuticals Market Outlook, By Recombinant Human Growth Hormones (2021-2030) ($MN)
Table 27 Global Biopharmaceuticals Market Outlook, By Recombinant Insulin (2021-2030) ($MN)
Table 28 Global Biopharmaceuticals Market Outlook, By Recombinant Enzymes (2021-2030) ($MN)
Table 29 Global Biopharmaceuticals Market Outlook, By Enterokinase (2021-2030) ($MN)
Table 30 Global Biopharmaceuticals Market Outlook, By Cyclase (2021-2030) ($MN)
Table 31 Global Biopharmaceuticals Market Outlook, By Caspase (2021-2030) ($MN)
Table 32 Global Biopharmaceuticals Market Outlook, By Cathepsin (2021-2030) ($MN)
Table 33 Global Biopharmaceuticals Market Outlook, By Cell and Gene Therapies (2021-2030) ($MN)
Table 34 Global Biopharmaceuticals Market Outlook, By Allogenic Products (2021-2030) ($MN)
Table 35 Global Biopharmaceuticals Market Outlook, By Autologous Products (2021-2030) ($MN)
Table 36 Global Biopharmaceuticals Market Outlook, By Acellular Products (2021-2030) ($MN)
Table 37 Global Biopharmaceuticals Market Outlook, By Synthetic Immunomodulators (2021-2030) ($MN)
Table 38 Global Biopharmaceuticals Market Outlook, By Cytokines (2021-2030) ($MN)
Table 39 Global Biopharmaceuticals Market Outlook, By Interferons (2021-2030) ($MN)
Table 40 Global Biopharmaceuticals Market Outlook, By Interleukins (2021-2030) ($MN)
Table 41 Global Biopharmaceuticals Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 42 Global Biopharmaceuticals Market Outlook, By Application (2021-2030) ($MN)
Table 43 Global Biopharmaceuticals Market Outlook, By Oncology (2021-2030) ($MN)
Table 44 Global Biopharmaceuticals Market Outlook, By Blood disorder (2021-2030) ($MN)
Table 45 Global Biopharmaceuticals Market Outlook, By Metabolic disease (2021-2030) ($MN)
Table 46 Global Biopharmaceuticals Market Outlook, By Infectious disease (2021-2030) ($MN)
Table 47 Global Biopharmaceuticals Market Outlook, By Cardiovascular disease (2021-2030) ($MN)
Table 48 Global Biopharmaceuticals Market Outlook, By Neurological disease (2021-2030) ($MN)
Table 49 Global Biopharmaceuticals Market Outlook, By Immunology (2021-2030) ($MN)
Table 50 Global Biopharmaceuticals Market Outlook, By Autoimmune Disorders (2021-2030) ($MN)
Table 51 Global Biopharmaceuticals Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
Table 52 Global Biopharmaceuticals Market Outlook, By Other Applications (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.